Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Covington
Moodys
UBS
Accenture
US Department of Justice
US Army
McKesson
Harvard Business School

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019615

« Back to Dashboard

NDA 019615 describes DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER, which is a drug marketed by Baxter Hlthcare and Hospira and is included in two NDAs. It is available from two suppliers. Additional details are available on the DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER profile page.

The generic ingredient in DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER is dopamine hydrochloride. There are nine drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the dopamine hydrochloride profile page.
Summary for 019615
Tradename:DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER
Applicant:Baxter Hlthcare
Ingredient:dopamine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 019615
Ingredient-typeCatecholamines
Medical Subject Heading (MeSH) Categories for 019615
Suppliers and Packaging for NDA: 019615
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 019615 NDA Baxter Healthcare Corporation 0338-1005 N 0338-1005-03
DOPAMINE HYDROCHLORIDE IN DEXTROSE 5% IN PLASTIC CONTAINER dopamine hydrochloride INJECTABLE;INJECTION 019615 NDA Baxter Healthcare Corporation 0338-1005 N 0338-1005-02

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength80MG/100ML
Approval Date:Mar 27, 1987TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength160MG/100ML
Approval Date:Mar 27, 1987TE:APRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength320MG/100ML
Approval Date:Mar 27, 1987TE:APRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Colorcon
Accenture
McKinsey
Cipla
McKesson
Johnson and Johnson
US Department of Justice
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.